ArticleBMC urology2018

Number-needed-to-treat analysis of clinical progression in patients with metastatic castration-resistant prostate cancer in the STRIVE and TERRAIN trials.

Neil M Schultz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.